These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8492424)

  • 1. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
    Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extramedullary pleural myelo-megakaryoblastic crisis during hematological chronic phase in chronic myeloid leukemia].
    Sakamoto Y; Kawachi Y; Abe T; Uchida T; Mori M; Setsu K
    Rinsho Ketsueki; 1994 Feb; 35(2):188-90. PubMed ID: 8139119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
    Koyama S; Aoki S; Furukawa T; Takahashi M; Kishi K; Koike T; Moriyama Y; Hattori A; Shibata A
    Rinsho Ketsueki; 1991 Dec; 32(12):1577-9. PubMed ID: 1779460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
    Goto H; Tsurumi H; Hara T; Moriwaki H
    Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural interferon-alpha induced cytogenetic complete remission in a patient with chronic myelocytic leukemia, diagnosed in early chronic phase with basophilia and normal blood cell counts].
    Koyama S; Moriyama Y; Aoki A; Furukawa T; Narita M; Wada K; Kishi K; Takahashi M; Koike T; Shibata A
    Rinsho Ketsueki; 1992 Feb; 33(2):227-31. PubMed ID: 1635174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
    Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryoblastic lineage of peripheral blood blasts of CML blast crisis identified by budding dysplastic platelets.
    Anand M; Kumar R; Singh S
    Am J Hematol; 2004 Apr; 75(4):239-40. PubMed ID: 15054817
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
    Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monocytic crisis in chronic myeloid leukemia: a case report].
    Sugita K; Nakazawa S; Mori T; Nishino K; Abe T; Gonda T; Aya M; Osano M; Takane K; Okazaki T
    Rinsho Ketsueki; 1989 Mar; 30(3):376-81. PubMed ID: 2769961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prominent lymphadenopathy and double Ph1 chromosomes as initial and recurrent manifestations of chronic myelogenous leukemia in blast crisis: report of a case and review of the literature].
    Sakai C; Minamihisamatsu M; Takagi T; Oguro M; Maruyama K; Tanaka K; Kamada N
    Rinsho Ketsueki; 1990 Sep; 31(9):1506-11. PubMed ID: 2246824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
    Kitabayashi A; Miura I; Ito T; Takahashi M; Chubachi A; Niitsu H; Mamiya S; Miura AB
    Rinsho Ketsueki; 1993 Jun; 34(6):733-7. PubMed ID: 8366576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.
    Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A
    Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psoriasis exacerbated by alpha-interferon therapy in a case of chronic myelogenous leukemia].
    Matsuoka H; Uno H; Nakama N; Maeda K; Tsubouchi H
    Rinsho Ketsueki; 1994 Mar; 35(3):309-11. PubMed ID: 8158855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Megakaryoblastic crisis of chronic myelogenous leukemia cytological and clinical studies in three cases].
    Ikegami T; Hasegawa Y; Hanada T; Nakazawa M; Abe T
    Rinsho Ketsueki; 1989 Jun; 30(6):898-903. PubMed ID: 2795902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
    Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
    Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].
    Maeda T; Ashie T; Kikuiri K; Ishiyama N; Takakura M
    Rinsho Ketsueki; 1989 Jul; 30(7):1032-6. PubMed ID: 2810787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
    Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
    Koike G; Otsuka T; Shibuya T; Niho Y
    Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.